INCAPS (Indianapolis) and BASi (West Lafayette) (NASDAQ: BASI) have announced a corporate alliance whereby the two contract research organizations will offer complementary services. INCAPS has a focus on proteomics and protein characterization studies using current and emerging technology platforms. BASi is focused on in-life safety and pharmacology assessment of new drug substances with a small molecule focus.
